Hemideina has raised funds via a private placement
Hemideina has raised US$7.4 million. The capital raised will be used to fund product development in preparation for the first human studies.
Hemideina is a Melbourne-based private company that is set to disrupt the cochlear implant market through its proprietary mechanical signal processing technology, the Hera wireless implant system. The company aims to provide a paradigm shift in hearing implant performance that will lead to increased access and adoption of treatment.
Oaklins’ team in Australia acted as lead manager in this transaction. The team has assisted Hemideina with fundraising since 2018 and is proud to support them on their mission to positively impact the lives of people with severe-to-profound hearing loss.
Elizabeth Williams
CEO and Co-founder, Hemideina
Talk to the deal team
Related deals
Royal Reesink has sold Motrac Industries to Anders Invest
Royal Reesink and Anders Invest have completed the sale of Motrac Industries, a specialist in hydraulic and electrical engineering.
Learn moreÑaming, SL has been acquired by DeA Capital S.p.A.
Spain’s leading producer of sandwiches, fresh and ultra-fresh products, Ñaming, has sold a majority stake to Italian fund DeA Capital.
Learn moreUniKidz has partnered with Karmijn Kapitaal
Karmijn Kapitaal has acquired a majority stake in UniKidz, a talent development organization that provides a scientifically-based developmental approach through high-quality childcare. Through the partnership with Karmijn Kapitaal, UniKidz can take the next step in bringing their unique concept to even more children.
Learn more